The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis
Abstract Background The American Neurogastroenterology and Motility Society Gastroparesis Cardinal Symptom Index-Daily Diary (ANMS GCSI-DD) was developed to meet Food and Drug Administration (FDA) recommendations for patient-reported outcome (PRO) endpoints in gastroparesis studies, including therap...
Main Authors: | Dennis A. Revicki, Sara Lavoie, Rebecca M. Speck, Jorge Puelles, Braden Kuo, Michael Camilleri, Cristina Almansa, Henry P. Parkman |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2018-12-01
|
Series: | Journal of Patient-Reported Outcomes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41687-018-0081-2 |
Similar Items
-
Diabetic gastroparesis: current challenges and future prospects
by: Avalos DJ, et al.
Published: (2018-09-01) -
Mirtazapine for symptom control in refractory gastroparesis
by: Malamood M, et al.
Published: (2017-03-01) -
CLINICAL FEATURES AND SEVERITY OF GASTRIC EMPTYING DELAY IN BRAZILIAN PATIENTS WITH GASTROPARESIS
by: Cláudio Marins Rocha BORGES, et al. -
Suffering in Silence: Is Gastroparesis Underdiagnosed?
by: Dennis J. Baumgardner
Published: (2019-04-01) -
Current perspectives on the management of gastroparesis
by: Rattansingh A, et al.
Published: (2005-01-01)